A carregar...
Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence
Despite great efforts in stroke research, disability and recurrence rates in ischaemic stroke remain unacceptably high. To address this issue, one potential target for novel therapeutics is the glycoprotein von Willebrand factor (vWF), which increases in thrombogenicity especially under high shear r...
Na minha lista:
| Publicado no: | Thromb Haemost |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Schattauer GmbH
2018
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6193403/ https://ncbi.nlm.nih.gov/pubmed/29847840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1648251 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|